Clinical trial
Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft…
NCT00261820 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00261820 |
|---|---|
| Title | Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients |
| Official title | A Randomized Study To Compare The Safety And Efficacy Of Two Immunosuppressive Regimens In De Novo Renal Allograft Recipients:Sirolimus Plus Mycophenolate Mofetil Plus Corticosteroids Following A Rabbit Anti-Human Thymocyte Globulin Induction (RATG) Vs Tacrolimus Plus Mycophenolate Mofetil Plus… |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Graft Rejection, Kidney Failure, Kidney Transplantation |
| Intervention type | Drug |
| Interventions | tacrolimus, mycophenolate mofetil, methylprednisolone, prednisolone, sirolimus |
| Enrollment | 160 |
| Completion | Jan 1, 2005 |
| First posted | Dec 5, 2005 |
| Last update posted | May 19, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: